Special Issue "The Legacy of the Nobel Prize for Medicine Awardee Renato Dulbecco 10 Years Later: The Post-Genomic Era"
Deadline for manuscript submissions: closed (10 October 2022) | Viewed by 7938
Interests: nonalcoholic fatty liver disease; alcoholic liver disease; gut microbiota; Mediterranean diet; nutrition; COVID-19; probiotic
Special Issues, Collections and Topics in MDPI journals
Special Issue in Medicina: Research Progress of Microbiota and Fecal Transplantation
Special Issue in Diseases: COVID-19 and Global Chronic Disease II
Special Issue in Medicina: Recent Advances and Future Challenges in Gastroenterology and Hepatology
Special Issue in Diseases: COVID-19 and Global Chronic Disease 2023
Special Issue in Medicina: Editorial Board Members’ Collection Series: Gastrointestinal and Hepatic Diseases
Nobel Prize Awardee Renato Dulbecco has been a pioneer of the investigation of the genetic mechanisms underlying cancer and other complex disorders and is one of the major promoters of the Human Genome Project. Ten years after his departure, his legacy still inspires generations of physicians and researchers in the critical journey toward the post-genomic era. Dulbecco has been a highly influential figure in the field of genetic research and the world scientific community.
The aim of the Special Issue is to highlight the role of Dulbecco in trailblazing the path to genomic medicine: from his contributions to cancer research to the lessons of the Human Genome Project. It will include considerations on how the sequencing of our genome has changed science and opened the door to translational science and precision medicine.
Cutting-edge research includes the following: translational research from genetics to genomics and other omics (epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics); next-generation sequencing and direct-to-consumer genetic tests; new awareness of the interaction between genome and environment; ethical challenges of the post-genomic era; focus on how genetic knowledge has changed the approach to the investigation of complex disorders.
We are soliciting research papers, short reports, reviews, systematic reviews, meta-analyses, letters to the Editor, and commentary papers.
Dr. Ludovico Abenavoli
Dr. Luigi Boccuto
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Human Genome Project
- translational medicine
- precision medicine
- clinical practice